<?xml version='1.0' encoding='UTF-8' standalone='no'?>
<!DOCTYPE frameset PUBLIC "-//PB//PropBank Frame v3.4 Transitional//EN" "http://propbank.org/specification/dtds/v3.4/frameset.dtd">
<frameset>
  <predicate lemma="hyperphosphorylate">
    <roleset id="hyperphosphorylate.01" name="phosphorylate fully, so that all potential phosphorylation sites are occupied">
      <aliases>
        <alias pos="v">hyperphosphorylate</alias>
        <alias pos="n">hyperphosphorylation</alias>
      </aliases>
      <roles>
        <role descr="intentional agent of hyperphosphorylation (e.g. scientist)" f="PAG" n="0"/>
        <role descr="thing hyperphosphorylated (e.g. protein or another organic molecule)" f="PPT" n="1"/>
        <role descr="instrument (e.g. enzyme)" f="MNR" n="2"/>
        <role descr="result of hyperphosphorylation" f="PRD" n="3"/>
      </roles>
      <usagenotes>
        <usage resource="PropBank" version="1.0" inuse="-"/>
        <usage resource="PropBank" version="2.1.5" inuse="-"/>
        <usage resource="PropBank" version="3.1" inuse="+"/>
        <usage resource="PropBank" version="3.4" inuse="+"/>
        <usage resource="AMR" version="2019" inuse="+"/>
        <usage resource="PropBank" version="Flickr 1.0" inuse="+"/>
        <usage resource="AMR" version="Spatial 1.0" inuse="+"/>
        <usage resource="AMR" version="THYME 1.0" inuse="+"/>
        <usage resource="PropBank" version="3.5" inuse="+"/>
        <usage resource="AMR" version="iSAT 1.0" inuse="+"/>
      </usagenotes>
      <example name="example with agent" src="">
        <text>If we hyperphosphorylate eIF4E - binding protein 1 , this stops it binding to eIF4E.</text>
        <propbank>
          <rel relloc="2">hyperphosphorylate</rel>
          <arg type="ARG0" start="1" end="1">we</arg>
          <arg type="ARG1" start="3" end="7">eIF4E - binding protein 1</arg>
        </propbank>
      </example>
      <example name="example with result" src="">
        <text>The pre - mRNA has to reach a length of 25 nt before the C - terminal end of RNAP II can be hyperphosphorylated to form the elongation complex .</text>
        <propbank>
          <rel relloc="23">hyperphosphorylated</rel>
          <arg type="ARG1" start="14" end="20">C - terminal end of RNAP II</arg>
          <arg type="ARG3" start="27" end="28">elongation complex</arg>
        </propbank>
      </example>
      <example name="example with instrument" src="">
        <text>HSV-1 serine / threonine kinase US3 hyperphosphorylates IRF3 and inhibits the IFN - Î² production ( P1413 ) .</text>
        <propbank>
          <rel relloc="6">hyperphosphorylates</rel>
          <arg type="ARG1" start="7" end="7">IRF3</arg>
          <arg type="ARG2" start="0" end="5">HSV-1 serine / threonine kinase US3</arg>
        </propbank>
      </example>
      <note>For Bio-AMR annotations.</note>
    </roleset>
  </predicate>
</frameset>
